Blood Cancers Showcase 2026

Date: November 11, 2026 - November 11, 2026
Type: In-person
Location: North America
Areas of Interest: Blood Cancers

The Next Frontier in Blood Cancer Genomics

You are invited to join our networking event on hematologic malignancies during the 2026 Association of Molecular Pathologists Annual Meeting & Expo in Seattle, USA.

Connect with peers and leading experts to explore how NGS-based solutions are helping labs keep pace with evolving guidelines and deliver meaningful insights while keeping their workflow efficient and cost-effective.

During this event, speakers from renowned institutions will share real-world experiences implementing high-sensitivity applications and translating complex molecular findings to real clinical impact.

This is your opportunity to learn how peers are overcoming complexity across the entire workflow, from library prep, to patient-centered interpretation.

About the Event

What: An Educational Networking Dinner
Where: TBC
Date: Wednesday, November 11th
Time: 6:30 pm – 8:15pm

Agenda

Introduction
Brandon Bullough - Product Marketing Director, Blood Cancers, SOPHiA GENETICS

From Assay Development to Clinical Utility: High-Sensitivity Clonal Hematopoiesis Testing
Gang Zheng, M.D., Ph.D.
Co-director Clinical Genomics Laboratory, Professor of Laboratory Medicine and Pathology, Mayo Clinic

Lessons from a molecular tumor board
Todd C. Knepper, PharmD
Associate Member in Precision Oncology, Department of Pathology, Moffitt Cancer Center

Reserve your seat to this exclusive event on Wednesday, November 11th starting at 6:30 pm.

Register Now

Email

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Company(Required)

Job Title(Required)

Area of Interest(Required)

Email(Required)

Phone

Country(Required)

Select US State(Required)

Privacy Policy(Required)

By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy

Marketing Opt-In

I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

3rd Party Opt-In

I agree that SOPHiA GENETICS may share my webinar registration details with 3rd parties, and that I may receive marketing communications from these 3rd parties. I understand that I can withdraw my consent at any time.

Job Title/Industry(Required)

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are those of the speakers and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services